Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans

Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Author(s)
Tien PC

Article PDF
025030012.pdf
Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Issue
Federal Practitioner - 25(3)
Publications
Federal Practitioner
Topics
HIV
Hepatitis
Page Number
12
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Commentary
Author(s)
Tien PC
Author(s)
Tien PC
Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Author and Disclosure Information

Phyllis C. Tien, MD

Dr. Tien is a staff physician in the infectious disease section of the San Francisco VA Medical Center and an assistant professor of medicine at the University of California at San Francisco, both in San Francisco, CA. She was the lead author of the VA's recommendations for managing and treating hepatitis C virus infection in HIV-infected adults.

Article PDF
025030012.pdf
Article PDF
025030012.pdf

Issue
Federal Practitioner - 25(3)
Issue
Federal Practitioner - 25(3)
Page Number
12
Page Number
12
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
HIV
Hepatitis
Article Type
Article
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Display Headline
Emerging Challenges in the Management of HIV and Hepatitis C Virus Coinfection in Veterans
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Legacy Keywords
hepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosinehepatology, HIV, hepatitis C virus, HCV, highly active antiretroviral therapy, HAART, pegylated interferon, ribavirin, inhibitor, inhibitors, protease, PI, PIs, polymerase, nucleoside, nonnucleoside, reverse transcriptase, NRTI, NRTIs, NNRTI, NNRTIs, T cells, CCR5, raltegravir, didanosine
Sections
Commentary
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Tien PC